Forum on Immunopathological Diseases and Therapeutics
Overview
Forum on Immunopathological Diseases and Therapeutics is a scientific journal, published by Begell House since 2010 in English. The journal's country of origin is United States and its primary focus area is allergy & immunology.
Details
Details
Abbr.
For Immunopathol Dis Therap
Publisher
Begell House
Start
2010
End
2016
Frequency
Quarterly
p-ISSN
2151-8017
e-ISSN
2151-8025
Country
United States
Language
English
Specialty
Allergy & Immunology
Metrics
Metrics
h-index / Ranks: 13575
14
SJR / Ranks: 15488
104
CiteScore / Ranks: 15065
0.10
Recent Articles
1.
Haake D
For Immunopathol Dis Therap
. 2019 Feb;
7(3-4):167-174.
PMID: 30701122
The immune response is a cornerstone in the body's struggle against microbial pathogens. In ways that we do not yet completely understand, the mammalian immune response has evolved to identify...
2.
Porritt R, Crother T
For Immunopathol Dis Therap
. 2019 Jan;
7(3-4):237-254.
PMID: 30687565
, an obligate intracellular bacterial pathogen, has long been investigated as a potential developmental or exacerbating factor in various pathologies. Its unique lifestyle and ability to disseminate throughout the host...
3.
Sell S
For Immunopathol Dis Therap
. 2018 Jun;
7(3-4):225-236.
PMID: 29876142
The introduction of immunopathologic reaction classification in the 1960s led to a major advance in understanding immune effector mechanisms and how lesions of immunopathologic diseases developed. In this article, immunopathologic...
4.
Samuels D, Samuels L
For Immunopathol Dis Therap
. 2018 Jun;
7(3-4):205-212.
PMID: 29876141
, the spirochete that causes Lyme disease, exists in an enzootic cycle, alternating between a tick vector and a vertebrate host. To adapt to and survive the environmental changes associated...
5.
Bankhead T
For Immunopathol Dis Therap
. 2018 Jun;
7(3-4):191-204.
PMID: 29876140
is the causative bacterial agent of Lyme disease, the most prevalent tick-borne infection in North America. The ability of to cause disease is highly dependent on its capacity to evade...
6.
Underwood M
For Immunopathol Dis Therap
. 2017 Oct;
7(1-2):1-15.
PMID: 28966796
Premature infants are at increased risk for morbidity and mortality due to necrotizing enterocolitis (NEC) and sepsis. Probiotics decrease the risk of NEC and death in premature infants; however, mechanisms...
7.
Phair J, Detels R, Margolick J, Rinaldo C, Jacobson L, Martinez-Maza O, et al.
For Immunopathol Dis Therap
. 2017 Jul;
6(1-2):53-55.
PMID: 28706749
John Fahey was an integral member of the small group of investigators who developed the Multicenter AIDS Cohort Study (MACS) in the early 1980s. A major research theme in the...
8.
Epeldegui M, Martinez-Maza O
For Immunopathol Dis Therap
. 2017 Jul;
6(1-2):79-90.
PMID: 28702272
HIV infection is associated with a greatly elevated risk for the development of non-Hodgkin lymphoma (NHL), which while diminished, remains elevated in the highly active antiretroviral therapy (HAART) era. Chronic...
9.
Resop R, Uittenbogaart C
For Immunopathol Dis Therap
. 2017 Jul;
6(1-2):33-49.
PMID: 28670486
Emigration of mature naïve CD4 SP T cells from the human thymus to the periphery is not fully understood, although elucidation of the mechanisms that govern egress of T cells...
10.
Aziz N, Bonavida B
For Immunopathol Dis Therap
. 2017 Jun;
7(1-2):41-55.
PMID: 28616355
During the last decade, probiotics have been established to be important mediators of host immunity. Their effects on both innate and adaptive immunity have been documented in the literature. Although...